Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 4/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 2/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13588223 | 0.86 | ALDH1A1 (0.35) | ALDH1A1HSD17B10TSHRHPGDCYP1A2 | |
| SCHEMBL15946499 | 0.86 | ALDH1A1 (0.41) | ALDH1A1HSD17B10TSHRHPGDCYP1A2 | |
| SCHEMBL29790427 | 0.77 | HTR1B (0.46) | ALDH1A1HSD17B10TSHRHPGDCYP1A2 | |
| SCHEMBL194724 | 0.77 | HTR1B (0.46) | ALDH1A1HSD17B10TSHRHPGDCYP1A2 | |
| SCHEMBL3113317 | 0.76 | ADRA2B (0.43) | ALDH1A1HSD17B10TSHRHPGDMAPK1 | |
| SCHEMBL29592755 | 0.76 | ADRA2B (0.43) | ALDH1A1HSD17B10TSHRHPGDMAPK1 | |
| SCHEMBL24717764 | 0.76 | ALDH1A1 (0.39) | ALDH1A1HSD17B10TSHRHPGDCYP1A2 | |
| SCHEMBL29592477 | 0.75 | ADRA2B (0.33) | ALDH1A1CYP3A4ADRA2BADRA2CGAA | |
| SCHEMBL4838631 | 0.75 | ADRA2B (0.33) | ADRA2BADRA2C | |
| SCHEMBL3124235 | 0.75 | ADRA2B (0.33) | ALDH1A1CYP3A4ADRA2BADRA2CGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570858-B2 | Curable composition, cured product, cured film, display panel, and method for producing cured film | TOKYO OHKA KOGYO CO., LTD. (JP) | 2026-03-10 | — | — | US | disclosed |
| US-20240402602-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-12-05 | — | — | US | disclosed |
| US-20240384056-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-11-21 | — | — | US | disclosed |
| US-12139567-B2 | Curable composition, cured product, and compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-11-12 | — | — | US | disclosed |
| US-12129335-B2 | Curable composition, cured product, and compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-10-29 | — | — | US | disclosed |
| US-20240239922-A1 | PHOTOCURABLE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20240191003-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-06-13 | — | — | US | disclosed |
| US-20240192593-A1 | PHOTOSENSITIVE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-06-13 | — | — | US | disclosed |
| US-11981794-B2 | Curable composition, cured product, and compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-05-14 | — | — | US | disclosed |
| EP-4317196-A1 | PHOTOCURABLE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-02-07 | — | — | EP | disclosed |
| US-10640607-B2 | Curable composition, cured film, display panel, and method for producing cured product | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-05-05 | — | — | US | disclosed |
| US-10479879-B2 | Curable composition, cured product of the curable composition, and method of producing a cured product using the curable composition | TOKYO OHKA KOGYO CO., LTD. (JP) | 2019-11-19 | — | — | US | disclosed |
| US-20190031818-A1 | CURABLE COMPOSITION, CURED FILM, DISPLAY PANEL OR OLED LIGHT, AND METHOD FOR PRODUCING CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2019-01-31 | — | — | US | disclosed |
| US-20180334533-A1 | CURABLE COMPOSITION, CURED FILM, DISPLAY PANEL, AND METHOD FOR PRODUCING CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD (JP) | 2018-11-22 | — | — | US | disclosed |
| US-20180334586-A1 | CURABLE COMPOSITION, CURED PRODUCT, CURED FILM, DISPLAY PANEL, AND METHOD FOR PRODUCING CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2018-11-22 | — | — | US | disclosed |
| US-20180251626-A1 | CURABLE COMPOSITION, CURED PRODUCT OF THE CURABLE COMPOSITION, AND METHOD OF PRODUCING A CURED PRODUCT USING THE CURABLE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2018-09-06 | — | — | US | disclosed |
| US-9683150-B2 | Curable composition, adhesive, method of producing fiber-reinforced composite material, and fiber-reinforced composite material | TOKYO OHKA KOGYO CO., LTD. (JP) | 2017-06-20 | — | — | US | disclosed |
| EP-2930200-B1 | Curable composition, adhesive, method of producing fiber-reinforced composite material, and fiber-reinforced composite material | TOKYO OHKA KOGYO CO LTD (JP) | 2016-07-20 | — | — | EP | disclosed |
| EP-2930200-A1 | Curable composition, adhesive, method of producing fiber-reinforced composite material, and fiber-reinforced composite material | TOKYO OHKA KOGYO CO., LTD. (JP) | 2015-10-14 | — | — | EP | disclosed |
| US-20150252229-A1 | CURABLE COMPOSITION, ADHESIVE, METHOD OF PRODUCING FIBER-REINFORCED COMPOSITE MATERIAL, AND FIBER-REINFORCED COMPOSITE MATERIAL | TOKYO OHKA KOGYO CO., LTD. (JP) | 2015-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12139567-B2 | Curable composition, cured product, and compound | CROCC, RCSD1, CRYZ | ALDH1A1 2462/4885HSD17B10 4158/4885TSHR 3917/4885 |
| US-12570858-B2 | Curable composition, cured product, cured film, display panel, and method for producing cured film | C5, CFL1, C9 | ALDH1A1 1968/4885HSD17B10 4527/4885TSHR 967/4885 |
| US-20240402602-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | CHMP4B, PHOSPHO1, EXOSC9 | ALDH1A1 2515/4885HSD17B10 4241/4885TSHR 4660/4885 |
| US-20240384056-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | CHMP4B, PHOSPHO1, EXOSC9 | ALDH1A1 2498/4885HSD17B10 4233/4885TSHR 4661/4885 |
| US-20240192593-A1 | PHOTOSENSITIVE COMPOSITION | PPOX, ERCC1, ERCC5 | ALDH1A1 1414/4885HSD17B10 3320/4885TSHR 4858/4885 |
| US-12129335-B2 | Curable composition, cured product, and compound | CROCC, RCSD1, WDR5 | ALDH1A1 1884/4885HSD17B10 3664/4885TSHR 2678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.